Results 211 to 220 of about 46,388,210 (340)
L. Schropp +3 more
semanticscholar +1 more source
Tumor mutational burden as a determinant of metastatic dissemination patterns
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal +4 more
wiley +1 more source
Effects of Complex, Plyometric, and Traditional Resistance Training on Neuromuscular Performance in Highly Trained Male Soccer Players: A Randomized Controlled Trial. [PDF]
El-Ashker S +5 more
europepmc +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
The Value of High-Frequency Ultrasound and Color Doppler Flow Imaging in Assessing the Efficacy of Moderate-to-Severe Acne Vulgaris: A Prospective Single-Arm Study. [PDF]
Zheng L +7 more
europepmc +1 more source
Hart Career Center Offers Preparation and Assistance for Career Planning [PDF]
Evans ’12, Kasey
core +1 more source
The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli +7 more
wiley +1 more source

